NDC11 60505095303
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 60505-0953-03 | 60505-0953 |
| 60505-0953-3 | 60505-0953 |
| 60505-953-03 | 60505-953 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Azelastine hydrochloride and Fluticasone propionate | AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE | Apotex Corp. | 7bbc6514-bea3-0be0-e673-a8f6069025ff | 2026-09-08 | Warnings, Adverse reactions | 60505-0953-3 60505-0953 60505095303 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.